Jenoptik Balance Sheet Health
Financial Health criteria checks 4/6
Jenoptik has a total shareholder equity of €939.5M and total debt of €480.1M, which brings its debt-to-equity ratio to 51.1%. Its total assets and total liabilities are €1.7B and €741.3M respectively. Jenoptik's EBIT is €159.1M making its interest coverage ratio 7.4. It has cash and short-term investments of €58.7M.
Key information
51.1%
Debt to equity ratio
€480.11m
Debt
| Interest coverage ratio | 7.4x |
| Cash | €58.73m |
| Equity | €939.53m |
| Total liabilities | €741.33m |
| Total assets | €1.68b |
Recent financial health updates
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
May 30
Is Jenoptik (ETR:JEN) A Risky Investment?
Dec 20Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet
Jul 25We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
Apr 04Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly
Dec 06Is Jenoptik (ETR:JEN) A Risky Investment?
Sep 02Recent updates
Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 15Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Nov 14Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?
Oct 14Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?
Sep 28Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings
Aug 15Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet
Jun 12Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
May 30Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35
Apr 25Jenoptik AG's (ETR:JEN) P/E Is On The Mark
Apr 15Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's
Mar 30At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?
Mar 22Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult
Jan 07Is Jenoptik (ETR:JEN) A Risky Investment?
Dec 20Why Jenoptik AG (ETR:JEN) Could Be Worth Watching
Dec 05Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?
Sep 01Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?
Aug 11Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet
Jul 25Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30
May 07We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
Apr 04Should You Think About Buying Jenoptik AG (ETR:JEN) Now?
Feb 19Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly
Dec 06What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?
Nov 13Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?
Oct 28Is Jenoptik (ETR:JEN) A Risky Investment?
Sep 02When Should You Buy Jenoptik AG (ETR:JEN)?
Aug 13We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
May 19Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?
May 01Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Feb 14Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?
Jan 23Is Jenoptik (ETR:JEN) Using Too Much Debt?
Nov 07At €32.08, Is It Time To Put Jenoptik AG (ETR:JEN) On Your Watch List?
Oct 23Here's What To Make Of Jenoptik's (ETR:JEN) Decelerating Rates Of Return
Sep 23Estimating The Fair Value Of Jenoptik AG (ETR:JEN)
Aug 28Is Jenoptik (ETR:JEN) Using Too Much Debt?
Jul 27Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?
Jul 13The Returns On Capital At Jenoptik (ETR:JEN) Don't Inspire Confidence
May 17Calculating The Intrinsic Value Of Jenoptik AG (ETR:JEN)
May 04Jenoptik's (ETR:JEN) Conservative Accounting Might Explain Soft Earnings
Apr 01Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Mar 27Here's What Jenoptik AG's (ETR:JEN) Shareholder Ownership Structure Looks Like
Mar 14Is Jenoptik AG (ETR:JEN) The Right Choice For A Smart Dividend Investor?
Mar 02Investors Who Bought Jenoptik (ETR:JEN) Shares Five Years Ago Are Now Up 140%
Feb 17Financial Position Analysis
Short Term Liabilities: JEN's short term assets (€581.7M) exceed its short term liabilities (€254.3M).
Long Term Liabilities: JEN's short term assets (€581.7M) exceed its long term liabilities (€487.0M).
Debt to Equity History and Analysis
Debt Level: JEN's net debt to equity ratio (44.9%) is considered high.
Reducing Debt: JEN's debt to equity ratio has increased from 15.8% to 51.1% over the past 5 years.
Debt Coverage: JEN's debt is well covered by operating cash flow (39.6%).
Interest Coverage: JEN's interest payments on its debt are well covered by EBIT (7.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 16:52 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jenoptik AG is covered by 24 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Rothenaicher | Baader Helvea Equity Research |
| Gerhard Schwarz | Baader Helvea Equity Research |
| Lasse Stueben | Berenberg |